Fact based stock research
Bayer (DB:BAYN)


Bayer stock research in summary

bayer.com


Bayer shares have a HOLD rating. They are good value and are safely financed, but show below average growth. We recommend holding Bayer shares.


Latest Obermatt Ranks


Country Germany
Industry Pharmaceuticals
Index CDAX, EURO STOXX 50, DAX 30
Size class XX-Large

April 19, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: Bayer

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
71
76
82
79
STOCK GROWTH RANKS
59
45
9
9
STOCK SAFETY RANKS
39
44
58
68
COMBINED STOCK RANKS
63
67
88
64

Last update of Combined Rank: 19-Apr-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Bayer in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 19-Apr-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Bayer; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
71
40
2
3
PROFIT GROWTH
72
71
71
19
STOCK RETURNS
36
31
39
40
CONSOLIDATED RANK: GROWTH
59
45
9
9

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Bayer.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
26
26
57
47
REFINANCING
68
75
69
75
LIQUIDITY
30
38
55
56
CONSOLIDATED RANK: SAFETY
39
44
58
68

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Bayer and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Bayer from April 19, 2018.